52 results on '"Abignano G"'
Search Results
2. POS1336 MRI DIGITAL ARTERY VOLUME INDEX (DAVIX©) AS QUANTITATIVE, CONTINUOUS IMAGING OUTCOME MEASURE OF VASCULAR DISEASE IN SYSTEMIC SCLEROSIS
3. POS0146 BIOSAMPLES FROM VEDOSS PATIENTS SHOW CLASSIC PATHOLOGICAL SIGNS OF SCLERODERMA:OPPORTUNITY FOR A BIOLOGICAL DIAGNOSIS OF DISEASE
4. 404 Plaque Psoriasis patients with Psoriatic Arthritis demonstrate a reduced capacity to neutralise neutrophil derived elastase compared to plaque psoriasis patients without arthritis.
5. AB0142 EVIDENCE OF TYPE I INTERFERON ACTIVATION DURING VASCULAR MANIFESTATIONS OF SYSTEMIC SCLEROSIS
6. POS1267 LONG-TERM SURVEY STUDY OF THE IMPACT OF COVID-19 ON SYSTEMIC AUTOIMMUNE DISEASES. LOW DEATH RATE DESPITE THE INCREASED PREVALENCE OF SYMPTOMATIC INFECTION. ROLE OF PRE-EXISTING INTERSTITIAL LUNG DISEASE AND ONGOING TREATMENTS.
7. OP0269 A COMBINED CLINICAL AND BIOMARKER ALGORITHM TO PREDICT FVC DECLINE IN SYSTEMIC SCLEROSIS ASSOCIATED INTERSTITIAL LUNG DISEASE: RESULTS FROM AN INTERNATIONAL MULTICENTRE OBSERVATIONAL COHORT
8. POS0319 PERFORMANCE OF PATIENT REPORTED OUTCOMES (PROs) IN SCLERODERMA PATIENTS WITH REDUCED LUNG FUNCTION IN AN OBSERVATIONAL COHORT
9. POS1246 COVID-19 IN ITALIAN PATIENTS WITH RHEUMATIC AUTOIMMUNE SYSTEMIC DISEASES: RESULTS OF A NATIONWIDE SURVEY STUDY
10. THU0342 DECLINE IN SUBCLINICAL SYSTEMIC SCLEROSIS PRIMARY HEART INVOLVEMENT ASSOCIATES WITH POOR PROGNOSTIC FACTORS AND ACTIVE INTERSTITIAL LUNG DISEASE
11. SAT0321 CURRENT PATIENT REPORTED OUTCOMES (PROS) POORLY REFLECT CHANGES IN LUNG FUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
12. SAT0281 BIOSAMPLES FROM AT RISK SSC PATIENTS SHOW CLASSIC PATHOLOGICAL SIGNS OF SCLERODERMA: OPPORTUNITY FOR DIAGNOSIS OF PRE-CLINICAL SSC
13. FRI0226 OPTICAL COHERENCE TOMOGRAPHY OF THE SKIN DETECTS SCLERODERMA CHANGES IN CLINICALLY UNAFFECTED SKIN: AN OPPORTUNITY FOR EARLY DETECTION OF SYSTEMIC SCLEROSIS
14. THU0341 DIGITAL ARTERY VOLUME INDEX (DAVIX©) PREDICTS THE ONSET OF FUTURE DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS
15. SAT0305 PERFORMANCE OF HIGH FREQUENCY ULTRASOUND IN THE ASSESSMENT OF SKIN INVOLVEMENT IN SYSTEMIC SCLEROSIS
16. AB0617 OPTICAL COHERENCE TOMOGRAPHY IN THE ASSESSMENT OF SKIN FIBROSIS IN SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL STUDY
17. FRI0241 INFLUENCE OF PATIENT REPORTED ‘’ARTHRITIS ACTIVITY’’ IN DETERMINING SHAQ, HAQ-DI AND COCHIN SCORES IN SYSTEMIC SCLEROSIS
18. FRI0233 IMPACT AND ADHERENCE TO THE MEDITERRANEAN DIET IN SYSTEMIC SCLEROSIS ITALIAN PATIENTS: CORRELATION WITH GASTROINTESTINAL SYMPTOMS, MOOD DISTURBANCES AND QUALITY OF LIFE
19. Three‐dimensional nail imaging by optical coherence tomography: a novel biomarker of response to therapy for nail disease in psoriasis and psoriatic arthritis
20. FRI0328 Targeted therapy using intradermal injection of etanercept for remission induction in discoid lupus erythematosus (TARGET-DLE): first results from a proof-of-concept phase 2 trial
21. THU0393 The predictor of malnutrition in systemic sclerosis (PREMASS) score: a validated combined index predictive of future weight loss in systemic sclerosis
22. FRI0443 Digital artery volume index: the first objective, automated, non-invasive imaging diagnostic of macrovascular involvement in ssc
23. SAT0507 Implantable loop recorder can screen for incidental significant arrhythmias in scleroderma, with cardiac mri ecv and troponin biomarker, useful for risk stratification
24. THU0409 Management of systemic sclerosis (SSC) related digital ulcers (DU) in expert tertiary centres: results from the analysis of the multicentre observational real-life desscipher/eustar study
25. AB0029 Anti inflammatory effect of pde5 inhibition: scope for a new potential indication in ssc associated myositis
26. FRI0390 European multicentre study validates elf test as biomarker of fibrosis in systemic sclerosis
27. THU0659 Skin microvascular flow assessed by dynamic optical coherence tomography: first non-invasive quantitative outcome measure of microvascular damage in systemic sclerosis
28. FRI0370 Three-dimensional nailfold capillary imaging by dynamic optical coherence tomography in systemic sclerosis: a validation study using nailfold video-capillaroscopy
29. FRI0646 Three-dimensional nail imaging by optical coherence tomography: a novel biomarker of response to therapy for nail disease in psoriasis and psoriatic arthritis
30. Use of optical coherence tomography for the diagnosis of preclinical lesions of circumscribed palmar hypokeratosis
31. SAT0229 A Novel Serum Test Based Algorithm To Aid in Very Early Diagnosis of Systemic Sclerosis (VEDOSS)
32. THU0509 Optical Coherence Tomography Description of Tophi in Gout Shows that Irregular Tophus Morphology, Oedema and Absence of Capsule Are Associated with Symptomatic Disease
33. FRI0239 Complementary Value of ELF Test and NT-proBNP in Reflecting Fibrosis and Vasculopathy in Systemic Sclerosis
34. SAT0198 The Desscipher Project in Systemic Sclerosis (SSC): Observational Data on Digital Ulcers (DU) Prevention from The Eustar Group
35. SAT0467 The Five Prospective Observational Trials of the International Systemic Sclerosis FP7-Health Research Project Desscipher: A Interim Report
36. FRI0466 Digital Artery Flow Index by Non-Contrast Magnetic Resonance Angiography of the Hand: A Quantitative Outcome Measure of Fibroproliferative Vasculopathy in Raynaud's Phenomenon of Scleroderma
37. SAT0313 Longitudinal Assessment of Scleroderma Skin by Optical Coherence Tomography: Preliminary Validation of Sensitivity to Change Over-Time
38. SAT0321 The Absence of SSC Pattern at NFC Carries A 90% Negative Predictive Value for the Classification of Very Early or Established SSC in an Unselected Cohort of Patients with Raynaud's Phenomenon; Experience from A Single Tertiary Centre: Table 1.
39. AB0803 Factors influencing health assessment questionnaire-disability index in systemic sclerosis: implication of comorbidities
40. FRI0256 Arthralgias are predictive factors of foot involvement evaluated by ultrasonography in patients with systemic sclerosis: A prospective study
41. OP0228 Optical coherence tomography validation: A new quantitative imaging biomarker for affected skin in scleroderma
42. SAT0022 Palmoplantar specific long NCRNA hotair drives myofibroblasts specific signature in systemic sclerosis
43. FRI0405 Sub-analysis of elf score biomarkers components indicates a specific correlation with different organ involvement in systemic sclerosis
44. SAT0199 Video-Capillaroscopy Assessment of Peri-Calcinotic Skin Indicates Specific Features of Severe Vasculopathy Associated with Calcium Deposits in Systemic Sclerosis.
45. Basic Science * 208. Stem Cell Factor Expression is Increased in the Skin of Patients with Systemic Sclerosis and Promotes Proliferation and Migration of Fibroblasts in vitro
46. S.7.1 Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biological and radiographic findings
47. Hypocomplementemia in systemic sclerosis
48. Survival and death causes in 251 systemic sclerosis patients from a single Italian center
49. Hypocomplementemia in systemic sclerosis- author reply
50. Myofibroblast specific gene expression signature in systemic sclerosis, more than TGF- induced activation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.